These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35059392)

  • 1. The Wnt Signaling Pathway in Diabetic Nephropathy.
    Wang H; Zhang R; Wu X; Chen Y; Ji W; Wang J; Zhang Y; Xia Y; Tang Y; Yuan J
    Front Cell Dev Biol; 2021; 9():701547. PubMed ID: 35059392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1 Suppresses SATB1 Transcription and Inactivates the Wnt/β-Catenin Pathway to Alleviate Diabetic Nephropathy in a Mouse Model.
    Zhu H; Peng J; Li W
    Diabetes Metab Syndr Obes; 2021; 14():3975-3987. PubMed ID: 34531670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress on Podocyte Pyroptosis in Diabetic Nephropathy.
    Zhu R; Bai X; Xu C; Qi W; Luo P; Wu M; Luo M
    Curr Med Chem; 2024 May; ():. PubMed ID: 38808713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
    Marshall CB
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.
    Hu C; Sun L; Xiao L; Han Y; Fu X; Xiong X; Xu X; Liu Y; Yang S; Liu F; Kanwar YS
    Curr Med Chem; 2015; 22(24):2858-70. PubMed ID: 26119175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling.
    Zhao C; Gao J; Li S; Liu Q; Hou X; Liu S; Xing X; Sun M; Wang S; Luo Y
    Biomed Res Int; 2018; 2018():6938482. PubMed ID: 30420966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of upstream stimulatory factor 2 in diabetic nephropathy.
    Wang S
    Front Biol (Beijing); 2015 Jun; 10(3):221-229. PubMed ID: 26494984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy.
    Deng J; Liu Y; Liu Y; Li W; Nie X
    J Inflamm Res; 2021; 14():5273-5290. PubMed ID: 34703268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
    Zeng LF; Xiao Y; Sun L
    Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy.
    Xuan C; Xi YM; Zhang YD; Tao CH; Zhang LY; Cao WF
    Front Pharmacol; 2021; 12():624404. PubMed ID: 33912044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy.
    Xiao L; Wang M; Yang S; Liu F; Sun L
    Biomed Res Int; 2013; 2013():987064. PubMed ID: 24455745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway.
    Huang B; Han R; Tan H; Zhu W; Li Y; Jiang F; Xie C; Shi R
    Biol Pharm Bull; 2023 Oct; ():. PubMed ID: 37853616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
    Dai H; Liu Q; Liu B
    J Diabetes Res; 2017; 2017():2615286. PubMed ID: 28791309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signaling cascade of miRNAs in causing Diabetes Nephropathy.
    Padmashree DG; Swamy NR
    Bioinformation; 2013; 9(8):401-8. PubMed ID: 23750089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.